Approved Hospital Formulary
Suggestions or Corrections? Above and Beyond Nominations Formulary Request
Show Therapeutic Classes
QR Code Add Formweb to your mobile device
Android iOS
Medications not yet evaluated by P&T are considered NON-FORMULARY. Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step!
Please be sure to document all clinical activities daily.
Approved Hospital Formulary
Suggestions or Corrections? Above and Beyond Nominations Formulary Request
Search results for:

brimonidine ophthalmic

brimonidine ophthalmic
Drug Name Form Strength Formulary Unrestricted Formulary Restricted Non-Formulary Interchange
Lumify SOLUTION, OPHTHALMIC 0.025%    
Alphagan P SOLUTION, OPHTHALMIC 0.1%, 0.15%    
Alphagan SOLUTION, OPHTHALMIC 0.2%      
VIEW MORE alpha-Adrenergic Agonists
Comments:

Alphagan 0.2% is the formulary workhorse agent.

Interchange Alphagan P 0.1% and Alphagan P 0.15% sol. to Alphagan 0.2%.

 

ORDERED FORMULATION

THERAPEUTIC INTERCHANGE

NOTES
brimonidine ophthalmic (Lumify)
  • 0.025% ophthalmic solution
ocular lubricant (Artificial Tears)
  • ophthalmic solution

If ineffective:

tetrahydrozoline ophthalmic (Visine)
  • 0.05% ophthalmic solution
Interchange at same dosing frequency

 

 

Reviewed:  July 24, 2007 (Alphagan P), and 26 March 2019 (Lumify)

Updated: June 2024 (Alphagan & Alphagan P)

Brimonidine Ophthalmic Solution (Alphagan/Alphagan P) Update

Last updated: Jul. 11, 2024






This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.

Copyright © 2026 Rpharmy, LLC ­ All Rights Reserved